Biopharmaceutical Growth in China:Bioprocessing Challenges Are Creating CMO Opportunities

摘要

In the past decade, the world has seen rapid growth of more than 15% in China's biopharmaceutical market (l). According to the second edition of BioPlan's Advances in Biopharmaceutical Technology in China, the most populous country in the world — with the largest patient groups - has a growing economy with its GDP second only to that of the United States. Rapid urbanization and greater access to national healthcare insurance puts China in second place after the United States for the largest market for pharmaceuticals - $122.6 billion in 2017 (l). With its surging middle class and increasing demand for medicines, the country is expected to sustain rapid growth throughout the next decade.